In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin

Infections due to Runyon group IV atypical mycobacteria, Mycobacterium fortuitum and Mycobacterium chelonei, in humans have been difficult to treat in the past because of the organisms' resistance to all of the conventional antimycobacterial drugs. Determinations of minimal inhibitory concentra...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1978-03, Vol.137 (3), p.318-321
Main Authors: Dalovisio, J R, Pankey, G A
Format: Article
Language:English
Subjects:
Amikacin - pharmacology
Kanamycin - analogs & derivatives
Microbial Sensitivity Tests
Mycobacterium - drug effects
Species Specificity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Infections due to Runyon group IV atypical mycobacteria, Mycobacterium fortuitum and Mycobacterium chelonei, in humans have been difficult to treat in the past because of the organisms' resistance to all of the conventional antimycobacterial drugs. Determinations of minimal inhibitory concentrations (MICs) by the agar dilution method suggest that amikacin may be useful in the treatment of infections due to M. fortuitum and M. chelonei. Further support for the efficacy of antimicrobial agents with good in vitro activity in the treatment of infections with M. fortuitum and M. chelonei will depend on correlation of future clinical experience with standardized data on the MICs for these organisms.
ISSN:0022-1899